Roche Glycart Ag
Patents = 68
Forward Citations = 987
where 'Filed Patents' based on already Granted Patents
where 'Inventors Filed' based on already Granted Patents
160 inventors (with patents filed for the assignee):
Roche Glycart AG is a subsidiary of Roche Group, a global pioneer in pharmaceuticals and diagnostics. Located in Switzerland, Roche Glycart specializes in the research and development of novel therapeutic antibodies and antibody engineering technologies. Their focus lies in providing innovative solutions for the treatment of various diseases including cancer and autoimmune disorders. With a commitment to improving patients' lives, Roche Glycart continues to advance the field of biotechnology and contribute to the advancement of healthcare.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com